Conditions: Rhinitis, Allergic, Perennial
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 261
Healthy volunteers: no

Brief summary:
Efficacy and safety of GW685698X (55 µg/day, q.d.) nasal spray over a period of 2 weeks in Japanese paediatric subjects ages 6 to \< 15 years with perennial allergic rhinitis will be evaluated compared with placebo.

Detailed description:

Arms:
arm 1: GW685698X 55mcg/day arm 2: Placebo

Interventions: intervention 1: Fluticasone furoate intervention 2: Placebo
Intervention descriptions: intervention 1: 55 mcg/day, intranasal, 2 weeks intervention 2: Placebo, intranasal, 2 weeks

Protocol document: